Tag: Host-directed therapeutics

A synthetic dual TLR7/8 agonist designated HYBRID2 successfully eliminated Leishmania donovani parasites in vitro while activating macrophage oxidative defenses.

A new review finds that mRNA vaccines and host-directed therapeutics for multidrug-resistant ESKAPE bacteria remain preclinical, with no licensed bacterial ...

A groundbreaking discovery in the field of antiviral therapy has emerged from Hiroshima University, highlighting the potential of a new ...